ASCO 2026 to feature Greenwich LifeSciences research poster

ASCO 2026 to feature Greenwich LifeSciences research poster
Greenwich LifeSciences secures ASCO slot

Greenwich LifeSciences, Inc. has announced the acceptance of its abstract and associated poster for publication at the upcoming 2026 ASCO Annual Meeting.

This development underscores the company's ongoing research efforts in oncology and its engagement with the global scientific community. The acceptance marks another milestone for Greenwich LifeSciences as it seeks to advance its clinical pipeline and gain further recognition within the industry.

Greenwich LifeSciences previously moved to secure new patent claims following statistically significant immune response data from its FLAMINGO-01 study, according to a recent disclosure. The company also announced a strategic update on its financing approach as it navigated current market conditions. These developments reflect continued efforts to support its clinical and operational initiatives.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.